Cenovus Energy climbs as oil prices strengthen and investors refocus on cash returns

Cenovus Energy Inc. (CVE) is up 4.1% today. Here is some analysis on what might have caused this price movement.

Analysis: Cenovus shares appear to be rising alongside a stronger crude-oil tape, which tends to lift Canadian oil sands producers due to their leverage to benchmark prices. The move may also reflect ongoing investor focus on Cenovus’s free-cash-flow profile and shareholder returns following its recent results and integration progress related to MEG.

Details:

Cenovus disclosed fourth-quarter 2025 free funds flow of about $1.3 billion alongside record upstream production of 917,900 BOE/d, which can reinforce expectations for resilient cash generation.

The company highlighted significant shareholder returns in the quarter (including common share repurchases and dividends), a theme that can support energy equities during commodity upswings.

Cenovus has an approved normal course issuer bid that allows continued buybacks through November 2026, which can add incremental demand for shares over time.

Crude prices have been volatile and recently elevated amid geopolitical supply-risk headlines, a backdrop that often benefits upstream-heavy names like Cenovus.

Sources:

Cenovus Energy, YCharts, Le Monde

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CVE Hedge Fund Activity

We have seen 247 institutional investors add shares of $CVE stock to their portfolio, and 194 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL WORLD INVESTORS removed 43,508,576 shares (-27.9%) from their portfolio in Q4 2025, for an estimated $736,165,105
CAPITAL RESEARCH GLOBAL INVESTORS added 17,730,542 shares (+16.6%) to their portfolio in Q4 2025, for an estimated $300,000,770
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 16,885,137 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $286,878,477
GOLDMAN SACHS GROUP INC removed 12,840,305 shares (-62.5%) from their portfolio in Q4 2025, for an estimated $217,257,960
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 12,564,179 shares (+440.8%) to their portfolio in Q4 2025, for an estimated $212,585,908
FIL LTD added 11,019,212 shares (+40.0%) to their portfolio in Q4 2025, for an estimated $186,445,067
BOSTON PARTNERS removed 8,817,157 shares (-39.7%) from their portfolio in Q4 2025, for an estimated $149,186,296

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CVE Analyst Ratings

Wall Street analysts have issued reports on $CVE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a "Outperform" rating on 11/17/2025
CIBC issued a "Outperformer" rating on 11/14/2025
TD Securities issued a "Buy" rating on 09/30/2025

To track analyst ratings and price targets for $CVE, check out Quiver Quantitative's $CVE forecast page.

$CVE Price Targets

Multiple analysts have issued price targets for $CVE recently. We have seen 6 analysts offer price targets for $CVE in the last 6 months, with a median target of $32.0.

Here are some recent targets:

Kevin Fisk from Scotiabank set a target price of $38.0 on 03/19/2026
Neil Mehta from Goldman Sachs set a target price of $29.0 on 03/12/2026
Manav Gupta from UBS set a target price of $36.0 on 02/20/2026
Greg Pardy from RBC Capital set a target price of $32.0 on 02/20/2026
Dennis Fong from CIBC set a target price of $32.0 on 11/14/2025
Menno Hulshof from TD Securities set a target price of $28.0 on 09/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.